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Introduction: New evidence indicates infections are emerging as risk factors for atherosclerosis although their
specific role in the development and progression of atherosclerosis is still unclear.
Case presentation: A 43-year-old Caucasian man who had been treated for four years for multiple sclerosis
progressively manifested systemic hypertension, polycythemia, peripheral arterial occlusion with intermittent
claudication, and persistent headaches. In 2006, an instrumental analysis (magnetic resonance imaging) of our
patient revealed widespread fibrocalcific atherosclerotic lesions which accounted for all his current symptoms,
including those related to microbial stimulus. Two particular aspects were of interest, namely a lack of conventional
cardiovascular risk factors and a negative family history for cardiovascular events. His chemical blood tests all
yielded negative findings although a low positive hepatitis C virus-ribonucleic acid titer was detected. The titer had
progressively increased and worsening atherosclerosis threatened the life of our patient. Interferon therapy was not
appropriate for our patient due to the severe adverse effects observed shortly after its administration.
Conclusions: The reaction of individual cells to infections may provide an explanation as to why individuals with a
similar microbial burden, corrected for the presence of other risk factors, display a different susceptibility to
developing or worsening atherosclerosis. The identification of susceptible individuals and the treatment even of
silent infections may provide an additional tool against atherosclerosis and its clinical complications. The evaluation
of cell susceptibility before and after the correction of risk factors may contribute to the assessment of the efficacy
of drug therapy.
Introduction
Atherosclerosis is the leading cause of death in the
majority of industrialized countries. The absence of “tra-
ditional” risk factors and the ready availability of new
therapeutic options are not sufficient to provide overall
protection against disease and its complications. Every
effort is being made by the scientific community to
identify conditions leading to disease of the arterial wall
and to find new diagnostic procedures for identifying
susceptible individuals. New lines of research have
begun to show evidence to indicate that infectious
agents are emerging as risk factors, although their role
in the development and progression of atherosclerosis is
still unclear.
Association of infections with atherosclerosis was first
reported in the 1970s [1]. Over the past decade aware-
ness of the possible association between atherosclerosis
and certain persistent bacterial and viral infections has
steadily increased [2-6]. Numerous reports have referred
to the contributory role in the atherosclerotic process
played by periodontal diseases, which have often been
associated with myocardial infarction and cerebrovascu-
lar events [7]. However, this association does not neces-
sarily prove the existence of atherogenic effects,
particularly in view of the widespread distribution of the
microorganisms involved.
Several authors have hypothesized that the number of
different pathogens to which an individual has been
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response capable of exacerbating atherosclerosis [7-9].
A case of severe atherosclerosis in a 43-year-old
patient who had no conventional risk factors, but with a
known hepatitis C virus (HCV), infection and an abnor-
mal immune cell response to infective stimuli, provided
us with the opportunity to re-examine the impact of
infections on cardiovascular diseases. In fact our case
suggests that in patients with a similar microbial burden,
but displaying a different susceptibility to atherosclerosis
even in the presence of other risk factors, individual
immune cell response to infective stimulus must be
taken into account.
Case presentation
A 43-year-old Caucasian man was referred to the
Department of Internal Medicine at the University
Teaching Hospital in Cagliari. His clinical manifestations
started in 2002 with a sudden onset of neurological
symptoms. Magnetic resonance imaging (MRI) of lesions
was consistent with a diagnosis of multiple sclerosis.
Our patient, employed as a prison officer, was not
deemed fit for work. In 2003, he was admitted to a
small community hospital where he was also diagnosed
with hypertension, polycythemia and intermittent clau-
dication. Finally, in 2006, he was referred to the Multi-
ple Sclerosis Centre at Cagliari University where a
vascular origin was postulated for his neurological
symptoms. Tests carried out on fibrocalcific athero-
sclerotic lesions accounted for the concomitant presence
of systemic hypertension, polycythemia, brain injury and
peripheral arterial occlusion. His electrocardiogram
(ECG) findings were normal, although due to a compro-
mised limb function, an exercise ECG could not be per-
formed. Ethical reasons also dissuaded us from
performing a coronary angiograph.
His family history for cardiovascular events was nega-
tive. A brain MRI revealed mild cortical atrophy with
bilateral lacunar ischemic lesions and gliosis in his cere-
bral white matter, mainly in the semi-oval center and
the corona radiata (Figure 1). The presence of extensive
arterial damage with bilateral atherosclerotic lesions was
revealed using color Doppler ultrasound. Abdominal
computed tomography (CT) angiography of his aorta
and lower limbs showed widespread fibrocalcific
Figure 1 MRI of our patient’sb r a i n . Mild cortical atrophy with
bilateral lacunar ischemic lesions and gliosis in the cerebral white
matter, mainly in the semi-oval center and the corona radiata.
Figure 2 Abdominal computed tomography angiography of
our patient’s aorta and lower limbs. Widespread fibrocalcific
atherosclerotic lesions are present. Both renal arteries and iliac
branches are affected by severe stenosis (70% to 85%). Tibial arteries
are occluded, thus preventing the examination of parts of the legs.
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and iliac branches were affected by severe stenosis (70%
to 85%). His tibial arteries were occluded, preventing us
from examining parts of his legs. A plaque determining
a 50% reduction in his left carotid gauge was also
revealed using color Doppler ultrasound. Blood tests
showed normal serum levels for lipids and glucose, and
his systemic inflammatory markers were all within
normal ranges (Table 1). Common thrombophilic condi-
tions and markers of immunological diseases all yielded
negative findings. Infection markers for human immu-
nodeficiency virus (HIV), toxoplasmosis, herpes I, II,
hepatitis B surface antigen (HBsAg) were also negative,
but a low titer of HCV-ribonucleic acid (RNA) was
found.
As our patient showed negative results for conven-
tional risk factors for atherosclerosis, we considered the
possibility that the disease was related to HCV infection.
However, no virus was detected in his lymphocytes,
monocytes and macrophages. These findings, together
with a suspected abnormal response to infective stimuli,
prompted us to investigate our patient’s immune cell
reactivity. Lipopolysaccharide (LPS), a Gram-pathogen
considered to be a potential contributor to the develop-
ment of atherosclerotic plaque even at extremely low
serum concentrations [10,11], was used to evaluate his
macrophage response. An abnormal reactivity of macro-
phages to LPS, exacerbated by our patient’s own serum,
was found; in fact this reaction mainly caused foam cell
formation (Figure 3) rather than pro-inflammatory cyto-
kine production (Figure 4). Neither LPS nor our
patient’s serum were capable of reproducing similar
effects on macrophages in healthy subjects. In addition
to the role played by viruses and other unknown factors,
these findings suggested the possibility that our patient’s
macrophages were unusually susceptible to infective
stimuli.
Our patient was prescribed the following: interferon-
gamma therapy was suspended to avoid its adverse
effects; atenolol 10 mg/day; amlodipine 10 mg/day; car-
dio-aspirin 100 mg/day; lansoprazole 30 mg/day; allo-
purinol 300 μg/day; escitalopram 10 mg/day; and
therapeutic bleeding about once a month.
HCV mRNA was first detected in 2006, the titer pro-
gressively increased but the criterion for interferon therapy
was only reached in 2007. Unfortunately, the therapy was
withdrawn because of the severe adverse effects observed
shortly after its administration (aplastic myelosis, beha-
vioral disturbance with depression, neurasthenia and anor-
exia). As our patient’s lipids and systemic inflammatory
markers were normal, it was not possible to prescribe con-
ventional therapy to counteract the progression of his
atherosclerosis. The disease is still worsening (the arterial
Table 1 Clinical characteristics of our patient.
Total cholesterol (mmol/L) 5.23 ESR (mm/h) 6
LDL-C (mmol/L) 2.59 Fibrinogen (μmol/L) 10.29
HDL-C (mmol/L) 1.76 IL-1b (pg/mL) 2.3 (n.v. < 3.9)
ApoA1 (g/L) 1.48 TNF-a (pg/mL) 9.5 pg/mL (n.v. < 15.6)
ApoB (g/L) 0.92 IL-6 (pg/mL) 0.5 ( < 3.13)
Triglycerides (mmol/L) 152 Leukocytes (mm
3) 8.500
Lp(a) (mg/L) 37 HCV-RNA (IU/mL) genotype 1b 396.000
Glucose (mmol/L) 4.9 Ab anti-CMV IgG (IU) 5.6 (n.v. < 0.4)
Homocysteine (μmol/L) 12.49 Ab anti-CMV IgM (IU/mL) 8 (n.v. < 15)
CRP (mg/ml) 6.5(n.v10)
CMV: cytomegalovirus; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; HCV: hepatitis C virus; IL: interleukin; Lp(a): Lipoprotein a; n.v.: normal values;
TNF-a: tumor necrosis factor alpha.
Figure 3 In this experiment, following the removal of non-
adherent cells, cells from our patient and controls were grown
in RPMI 1640 media, supplemented with 10% patient plasma,
while others cells were cultured in RPMI 1640 supplemented
with 10% AB serum. The cells were subsequently treated for 48
hours as depicted in the figure. Four hours before harvesting, the
cells received 74 KBq/mL of ^14C-oleate. After incubation the cells
were washed with ice-cold phosphate-buffered saline (PBS), and
lipids were extracted with acetone. Neutral lipids were then
separated and determined as described in material and methods
(Additional File 1). Each value represents the mean ± SEM of five
separate experiments (P < 0.05 versus the corresponding control).
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mitantly with the increase in his HCV titer.
Discussion
Despite an increasing number of studies performed to
investigate the association between infections and vascu-
lar diseases, no consensus has been reached to date on
the possible atherogenic effects of infectious agents. The
pathogenetic mechanisms underlying this disease remain
unclear, and the associations revealed do not necessarily
prove the existence of atherogenic effects, particularly in
view of the widespread distribution of the microorgan-
isms involved.
This case report suggests that in susceptible indivi-
duals the presence of a chronic infective stimulus may
directly activate metabolic pathways (such as cholesterol
esterification) leading to foam cell formation and thus
to atherosclerosis. Furthermore, it also implies that this
condition may be exacerbated by acute infections, as is
suggested by the exceedingly high rate of cholesterol
esterification found in patient macrophages incubated
with its own plasma plus LPS, but not found in control
cells. Thus, in patients with a similar microbial burden
who display a different susceptibility to atherosclerosis,
even in the presence of other risk factors, individual
immune cell response to infective stimulus should be
taken into account.
To the best of our knowledge this is the first case that
describes the molecular mechanisms by which macro-
phages respond to infective stimuli inducing foam cell
formation. We suggest that research on silent infections
and the evaluation of immune cell reactivity to micro-
bial injuries, could lead to the development of an addi-
tional strategy for preventing and controlling
atherosclerosis.
Conclusions
The reaction of individual cells to infections may pro-
vide an explanation as to why individuals with a similar
microbial burden, corrected for the presence of other
risk factors, display a different susceptibility to develop-
ing or worsening atherosclerosis. The identification of
susceptible individuals and the treatment of silent infec-
tions may provide an additional tool against athero-
sclerosis and its clinical complications. The evaluation
of cell susceptibility before and after the correction of
risk factors may contribute to the assessment of the effi-
cacy of drug therapy.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Figure 4 On day nine the macrophage monolayer was washed,
fresh culture medium was supplied, and cells cultured as
depicted in the figure for a further two days in the presence of
lipopolysaccharide. Cytokine secretion into the medium was
evaluated on day 11. Each value represents the mean ± SEM of five
separate experiments (P < 0.05 versus the corresponding control).
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Additional file 1: Materials and methods. The data provided discuss
the materials and methods used in plasma preparation, clinical chemistry,
cell isolation and culture, analysis of cholesterol-laden macrophages, cell
protein isolation and western blotting analysis, cytokine assay, cholesterol
esterification, and statistical analysis.
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